Catherine J. Betts - Concepedia

Author

Catherine J. Betts

Also Known As

C Betts, C J Betts, C. BETTS, C. Betts, C.J Betts, C.J. Betts, CATHERINE BETTS, CATHERINE J. BETTS, Catherine Betts, Catherine J Betts

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)Syngenta (United Kingdom)University of Manchester University of Liverpool Procter & Gamble (United States)

About

Catherine J. Betts is an author at AstraZeneca (United Kingdom) specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	647
2	Allergy	7	7	263
3	Biostatistics	4	4	79
4	Public Health	1	1	57
5	Biomedical Engineering	1	1	87

Catherine J. Betts

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Stat6 Signaling Promotes Protective Immunity Against <i>Trichinella spiralis</i> Through a Mast Cell- and T Cell-Dependent Mechanism Joseph F. Urban, Lisa Schopf, Suzanne C. Morris, The Journal of Immunology	2000	191
Mast cells, eosinophils and antibody‐mediated cellular cytotoxicity are not critical in resistance to <i>Trichuris muris</i> Catherine J. Betts, Kathryn J. Else Parasite Immunology T. Muris InfectionMast Cell DisorderImmunologyImmune RegulationImmunologic Mechanism	1999	101
A 3D Human Airway Model Enables Prediction of Respiratory Toxicity of Inhaled Drugs In Vitro Kinga Balogh Sivars, Ulf Sivars, Ellinor Hornberg, Toxicological Sciences AsthmaLung DepositionRespiratory ToxicologyMedicineRespiratory Toxicity	2017	87
Impaired immunity and altered pulmonary responses in mice with a disrupted interferon‐γ receptor gene exposed to the irradiated <i>Schistosoma mansoni </i>vaccine R. Alan Wilson, P S Coulson, Catherine J. Betts, Immunology	1996	79
An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves, Toxicological Sciences Cardiac MuscleHeart FailurePathologyCardiovascular ToxicityRat Model	2014	57
The local lymph node assay in practice: a current regulatory perspective Amanda Cockshott, Peter Evans, C. A. Ryan, Human & Experimental Toxicology Uk HealthImmunologyPathologyToxicology TestingImmunophenotyping	2006	50
Evaluation of Novel Renal Biomarkers with a Cisplatin Model of Kidney Injury: Gender and Dosage Differences Mark Pinches, Catherine J. Betts, Sue Bickerton, Toxicologic Pathology Novel Renal BiomarkersRenal PathologyRenal InflammationPathologyNew Biomarkers	2012	46
Exosomal Transport of Hepatocyte‐Derived Drug‐Modified Proteins to the Immune System Monday O. Ogese, Rosalind E. Jenkins, Kareena Adair, Hepatology	2019	42
The local lymph node assay and skin sensitization: a cut‐down screen to reduce animal requirements? Ian Kimber, Rebecca J. Dearman, Catherine J. Betts, Contact Dermatitis	2006	39
Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay Rebecca J. Dearman, Catherine J. Betts, Craig H. Farr, Contact Dermatitis Skin Sensitization PotencyAllergyWeak SkinSkin TestingMedicine	2007	39

Page 1